m+Medelevator.RU
← Поиск публикаций
Cell genomics · 2023

Multi-omics characterization of silent and productive HPV integration in cervical cancer.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Fan Junpeng, Fu Yu, Peng Wenju, Li Xiong, Shen Yuanming, Guo Ensong, Lu Funian, Zhou Shengtao, Liu Si, Yang Bin, Qin Xu, Hu Dianxing, Xiao Rourou, Li Xi, Yang Siqi, Yuan Cunzhong, Shu Yao, Huang He, Wan Ting, Pi Yanan, Wang Shuxiang, Chen Wenjuan, Wang Haixia, Zhong Lin, Yuan Li, Wen Baogang, Kong Beihua, Mills Gordon B, Zou Dongling, Xia Bairong, Song Kun, Chen Gang, Ma Ding, Sun Chaoyang

Аннотация

Cervical cancer (CC) that is caused by high-risk human papillomavirus (HPV) remains a significant public health problem worldwide. HPV integration sites can be silent or actively transcribed, leading to the production of viral-host fusion transcripts. Herein, we demonstrate that only productive HPV integration sites were nonrandomly distributed across both viral and host genomes, suggesting that productive integration sites are under selection and likely to contribute to CC pathophysiology. Furthermore, using large-scale, multi-omics (clinical, genomic, transcriptional, proteomic, phosphoproteomic, and single-cell) data, we demonstrate that tumors with productive HPV integration are associated with higher E6/E7 proteins and enhanced tumor aggressiveness and immunoevasion. Importantly, productive HPV integration increases from carcinoma in situ to advanced disease. This study improves our understanding of the functional consequences of HPV fusion transcripts on the biology and pathophysiology of HPV-driven CCs, suggesting that productive HPV integration should be evaluated as an indicator of high risk for progression to aggressive cancers.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты